Supernus Pharmaceuticals SUPN
$ 35.71
-1.14%
Quarterly report 2024-Q3
added 11-04-2024
Supernus Pharmaceuticals General and Administrative Expenses 2011-2024 | SUPN
Annual General and Administrative Expenses Supernus Pharmaceuticals
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|
377 M | 305 M | 201 M | 158 M | 160 M | 138 M | 106 M | 89.2 M | 72.5 M | 55.6 M | 20.1 M | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
377 M | 20.1 M | 153 M |
Quarterly General and Administrative Expenses Supernus Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69.8 M | 85.9 M | 86.5 M | - | 82.7 M | 86.8 M | 85.6 M | - | 112 M | 100 M | 90.5 M | - | 72 M | 69.5 M | 61.5 M | - | 54.5 M | 48.1 M | 41.6 M | - | 39.3 M | 39.8 M | 41 M | - | 40.9 M | 40.1 M | 36.8 M | - | 40.8 M | 35.1 M | 28.2 M | - | 25.7 M | 26.1 M | 25.2 M | - | 22.9 M | 23.2 M | 19.4 M | - | 17.4 M | 19.6 M | 17.5 M | - | 14.6 M | 12.2 M | 13.5 M | - | 4.08 M | 4.64 M | 2.73 M | - | 1.5 M | 1.9 M | 1.75 M |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
112 M | 1.5 M | 41.5 M |